AFT Pharmaceuticals develops, licenses, and sells a range of medical products globally. We believe that the key to improving people’s health lies in innovation.
Back in 1997, husband and wife team Hartley and Marree Atkinson hit the road selling products direct to pharmacies. AFT Pharmaceuticals was formed with a big dream in mind.
In Australasia, our product line now extends to over 130 prescription and non-prescription products. We have offices in Singapore, Kuala Lumpur, Sydney and Auckland (our HQ). We export or license our products to over 109 countries. Plus our Orphan Drugs Foundation provides access to lower cost pharmaceuticals for people with rare diseases within South East Asia and the Pacific.
This success has been built on research and development. R&D is more than corporate speak for us. It’s at the heart of what we do, whether it’s developing new products, or improving existing existing ones. It’s also due to the fact that we are close to the market. Because we sell our own products we are constantly looking for changes in health needs and how we can fill gaps that emerge.
Our ideas, our researchers, our specialist drug development programmes, and the international experts we partner with have allowed us to grow year on year. It’s how we’ve managed to forge a place on the world stage in the extremely competitive pharmaceutical industry.
We’re proud of our past achievements. We’re ambitious for the future.